Respecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers

Affiliations

• ¹ Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan.
• ² Precision Medicine Center, Aichi Cancer Center, Nagoya, Japan.
• ³ Division of Advanced Cancer Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ⁴ Department of Medicine, VCU School of Medicine, Richmond, VA, USA.
• ⁵ Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Richmond, VA, USA.